Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 23593203)

1.

The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.

Al-Chaqmaqchi H, Sadeghi B, Abedi-Valugerdi M, Al-Hashmi S, Fares M, Kuiper R, Lundahl J, Hassan M, Moshfegh A.

PLoS One. 2013 Apr 4;8(4):e60367. doi: 10.1371/journal.pone.0060367. Print 2013.

2.

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.

Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, Panoskaltsis-Mortari A, Munn DH, Murphy WJ, Azuma M, Yagita H, Fife BT, Sayegh MH, Najafian N, Socie G, Ahmed R, Freeman GJ, Sharpe AH, Blazar BR.

Blood. 2013 Oct 24;122(17):3062-73. doi: 10.1182/blood-2013-05-500801. Epub 2013 Sep 12.

3.

Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.

Fujiwara H, Maeda Y, Kobayashi K, Nishimori H, Matsuoka K, Fujii N, Kondo E, Tanaka T, Chen L, Azuma M, Yagita H, Tanimoto M.

J Immunol. 2014 Sep 1;193(5):2565-73. doi: 10.4049/jimmunol.1400954. Epub 2014 Jul 30.

PMID:
25080485
4.

Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Al-Hashmi S, Hassan Z, Sadeghi B, Rozell B, Hassan M.

Int J Clin Exp Pathol. 2011 Aug 15;4(6):596-605. Epub 2011 Jul 31.

5.

Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, Tanimoto M, Teshima T.

J Clin Invest. 2010 Jul;120(7):2370-8. doi: 10.1172/JCI39165. Epub 2010 Jun 7.

6.

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kwak KB, Peschon JJ, Taylor PA.

J Immunol. 2001 Mar 1;166(5):3174-83.

7.

Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.

Okiyama N, Katz SI.

J Autoimmun. 2014 Sep;53:1-9. doi: 10.1016/j.jaut.2014.06.005. Epub 2014 Jul 18.

PMID:
25047812
8.

Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation.

Scroggins SM, Olivier AK, Meyerholz DK, Schlueter AJ.

PLoS One. 2013 Sep 10;8(9):e75158. doi: 10.1371/journal.pone.0075158. eCollection 2013.

9.

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash SM, Ferrara JL.

Blood. 2003 Jul 15;102(2):763-71. Epub 2003 Mar 27.

10.

Effect and mechanism of acute graft versus host disease on early diffuse murine lung injury following allogeneic stem cell transplantation.

Ning J, Liu QF, Luo XD, Fan ZP, Zhang Y.

Sci China C Life Sci. 2009 Nov;52(11):1016-22. doi: 10.1007/s11427-009-0139-8. Epub 2009 Nov 24.

PMID:
19937199
11.

Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.

Li W, Wang X, Chen R, Zhu H, Chen G, Sun X.

J Surg Res. 2012 Aug;176(2):e79-87. doi: 10.1016/j.jss.2011.12.009. Epub 2011 Dec 30.

PMID:
22381170
13.
14.

Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.

Eyrich M, Burger G, Marquardt K, Budach W, Schilbach K, Niethammer D, Schlegel PG.

Biol Blood Marrow Transplant. 2005 May;11(5):371-82.

15.

Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.

Jang MJ, Kim HS, Lee HG, Kim GJ, Jeon HG, Shin HS, Chang SK, Hur GH, Chong SY, Oh D, Chung HM.

Acta Haematol. 2013;129(4):197-206. doi: 10.1159/000345267. Epub 2012 Dec 21.

PMID:
23257958
16.

PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.

Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.

Transplantation. 2007 Jul 27;84(2):214-22. Erratum in: Transplantation. 2008 Mar 27;85(6):910. Perikles, Simon [corrected to Simon, Perikles].

PMID:
17667813
17.

Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.

Li JM, Gorechlad J, Larsen CP, Waller EK.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1239-49.

18.

Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.

Glass B, Uharek L, Gassmann W, Focks B, Bolouri H, Loeffler H, Mueller-Ruchholtz W.

Ann Hematol. 1992 Jun;64(6):255-9.

PMID:
1637877
19.

Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.

Sang W, Zhou C, Cheng N, Li Z, Zeng L, Xu K.

Immunol Lett. 2011 May;136(2):194-202. doi: 10.1016/j.imlet.2011.01.010. Epub 2011 Jan 26.

PMID:
21277900
20.

IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.

Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ.

J Immunol. 2012 Aug 15;189(4):2033-42. doi: 10.4049/jimmunol.1102853. Epub 2012 Jul 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk